isirv

About Guides FAQs

Font Size

SCREEN

Profile

Direction

Menu Style

Apply Reset  

Return to menu 

Novel Antiviral Therapies for Influenza and Other Respiratory Viruses: Bench to Bedside  2 - 4 June 2015

Organising and Scientific Committees            

Organising Committee

Scientific Advisory Committee

Robert Krug - Chair
University of Texas at Austin
Austin
USA

Ruben Donis - Chair
Center for Disease Control and Prevention
Atlanta
USA
Alan Hay - Co-chair
NIMR
London
UK
 Michael Ison - Co-chair
Northwestern University Feinberg School of Medicine
Chicago
USA 
Regina Dutkowski
d3 Medicine, New Jersey
New Jersey                                                      USA
 Stephen Cusack
EMBL
Grenoble
France

Frederick Hayden

University of Virginia School of Medicine
Charlottesville
USA

John DeVincenzo
University of Tennessee School of Medicine
Memphis
USA

Mark Krystal
Bristol-Myers Squibb Company
New York
USA

George Gao
Chinese Academy of Sciences
Beijing
China

Jane Ryan
Consultant at Sementis
Australia

Amy Krafft
NIAID
Rockville, MD
USA

Jane Tao
Rice University
Houston
USA

Jenny McKimm Breschkin
CSIRO Materials Science and Engineering        
Parkville
Australia

Sylvie van der Werf
Institut Pasteur
Paris
France

Melissa Willis
Biomedical Advanced Research and Development Authority (BARDA)        
Washington
USA
Richard Whitley
The University of Alabama at Birmingham
Birmingham
USA                                                                      
Makoto Yamashita
University of Tokyo
Tokyo, Japan

Hui-Ling Yen
Division of Public Health Laboratory Sciences
The University of Hong Kong
Hong Kong SAR, China

Organising Committee

Bob Krug - Chairman
University of Texas at Austin
Austin
USA

ISIRV LTD - Registered Address: 54a Castle Road, Isleworth, Middlesex, England TW7 6QS | Registered Company Number: 6021083 (England & Wales) | Registered Charity Number: 1118829